Plasma visfatin level in women with polycystic ovary syndrome

Gynecological Endocrinology

Volumn 27, Issue 7, 2011, Pages 475-479

  Dikmen, Emre ^a   Tarkun, Ilhan ^a   Cantürk, Zeynep ^a   Çetinarslan, Berrin ^a  

^a KOCAELI UNIVERSITY   (Turkey)

Author keywords

insulin resistance; PCOS; Visfatin

Indexed keywords

ANDROGEN; ANDROSTENEDIONE; ESTRADIOL; FOLLITROPIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LUTEINIZING HORMONE; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; PRASTERONE SULFATE; PROGESTERONE; PROLACTIN; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; ANDROGEN BLOOD LEVEL; ANDROSTENEDIONE BLOOD LEVEL; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET RESTRICTION; ESTRADIOL BLOOD LEVEL; FEMALE; FOLLITROPIN BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HUMAN; HYPERANDROGENISM; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; OBESITY; OVARY POLYCYSTIC DISEASE; PATIENT ASSESSMENT; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; PROLACTIN BLOOD LEVEL; TESTOSTERONE BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

ADULT; BLOOD GLUCOSE; BODY MASS INDEX; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; OBESITY; OVERWEIGHT; POLYCYSTIC OVARY SYNDROME; WAIST CIRCUMFERENCE;

EID: 79958044680     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2010.495796     Document Type: Article

References (19)

1. Dunaif A. Insulin action in the polycystic ovary syndrome. Endocrinol Metab Clin North Am 1999;28:341-359. (Pubitemid 29242717)
2. Holte J. Disturbances in insulin secretion and sensitivity in women with polcystic ovary syndrome. Bailleries Clin Endocrinol Metab 1996;10:221-247. (Pubitemid 26166053)
3. Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocrinol Rev 1997;18:774-800. (Pubitemid 28009567)
4. Ehrmann DA, Barnes RB, Rosenfield RL, Cavaghan MK, Imperial J. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care 1999;22:141-146. (Pubitemid 29028311)
5. Fukuhara A, Matsuda M, Nishizawa M, Segawa K, Tanaka M, Kishimoto K, Matsuki Y, Murakami M, Ichisaka T, Murakami H, et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 2005;307:426-430. (Pubitemid 40139988)
6. MacLaren R, Cui W, Cianflone K. Visfatin expression is hormonally regulated by metabolic and sex hormones in 3T3- L1 pre-adipocytes and adipocytes. Diabetes Obes Metab 2007;9:490-497. (Pubitemid 47018512)
7. Berndt J, Klöting N, Kralisch S, Kovacs P, Fasshauer M, Schön MR, Stumvoll M, Blüher M. Plasma visfatin concentrations and fat depot specific m-RNA expression in humans. Diabetes 2005;54:2911-2916. (Pubitemid 41401086)
8. Zahorska-Markiewicz B, Olszanecka-Glinianowicz M, Janowska J, Kocełak P, Semik-Grabarczyk E, Holecki M, Dabrowski P, Skorupa A. Serum concentrations of visfatin in obese women. Metabolism 2007;56:1131-1134. (Pubitemid 47021180)
9. Chen MP, Chung FM, Chang DM, Tsai JC, Huang HF, Shin SJ, Lee YJ . Elevated plasma level of visfatin/pre-B cell colony enhancing factor in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 2006;91:295-299. (Pubitemid 43069152)
10. Dogru T, Sonmez A, Tasci I, Bozoglu E, Yilmaz MI, Genc H, Erdem G, Gok M, Bingol N, Kilic S, et al. Plasma visfatin levels in patients with newly diagnosed and untreated type 2 diabetes mellitus and impaired glucose tolerance. Diabetes Res Clin Pract 2007;76:24-29. (Pubitemid 46240362)
11. Pagano C, Pilon C, Olivieri M, Mason P, Fabris R, Serra R. Reduced plasma visfatin/pre B cell colony-enhancing factor in obesity is not related to insulin resistance in humans. J Clin Endocrinol Metab 2006;91:3165-3170. (Pubitemid 44271773)
12. Krzyzanowska K, Krugluger W, Mittermayer F, Rahman R, Haider D, Shnawa N, Schernthaner G. Increased visfatin concentrations in women with gestational diabetes mellitus. Clin Sci (London) 2006;110;605-609. (Pubitemid 43736123)
13. Tan BK, Chen J, Digby JE, Keay SD, Kennedy CR, Randeva HS. Increased visfatin mRNA and protein levels in adipose tissue and adipocytes in women with polycystic ovary syndrome (PCOS): paralel increase in plasma visfatin. J Clin Endocrinol Metab 2006;91:5022-5028. (Pubitemid 44917345)
14. Kowalska I, Strackowski M, Nikalajuk A, Adamska A, Karczewska-Kupczewska M, Otziomek E, Wolczynski S, Gorska M. Serum visfatin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome. Hum Reprod 2007;22:1824-1829. (Pubitemid 47062747)
15. Chan TF, Chen YL, Chen HH, Lee CH, Jong SB, Tsai EM. Increased plasma visfatin concentrations in women with polycystic ovary syndrome. Fertil Steril 2007;88:401-405.
16. Panidis D, Farmakiotis D, Rousso D, Katsikis I, Delkos D, Piouka A, Gerou S, Diamanti-Kandarakis E. Plasma visfatin levels in normal weight women with polycystic ovary syndrome. Eur J Int Med 2008;19:406-412.
17. Gen R, Akbay E, Muşlu N, Sezer K, Çayan F. Plasma visfatin level in lean women with PCOS: relation to proinflammatory markers and insulin resistance. Gynecol Endocrinol 2009;25:241-245.
18. Jongwutiwes T, Lertvikool S, Leelaphiwat S, Rattanasiri S, Jultanmas R, Weerakiet S. Serum visfatin in Asian women with polycystic ovary syndrome. Gynecol Endocrinol 2009;25:536-542.
19. Haider DG, Schindler K, Schaller G, Prager G, Wolzt M, Ludvik B. Increased plasma visfatin concentrations in morbidly obese subjects are reduced after gastric banding. J Clin Endocrinol Metab 2006;91:1578-1581.